Plant Advanced Technologies SA ( ALPAT.PA) Stock. Should you Buy or Sell? $ 16.95
0.10 (0.59 %)
Plant Advanced Technologies SA Analysis
Updated on 03-07-2022
| Symbol |
ALPAT.PA |
| Price |
$16.95 |
| Beta |
0.890 |
| Volume Avg. |
$349 |
| Market Cap |
$18.39 M |
| 52 Week Range |
$15.05 - $22.2 |
Plant Advanced Technologies SA opened the day at $16.95 which is +'0.59 % on yesterday's close.
Plant Advanced Technologies SA has a 52 week high of $22.2 and 52 week low of $15.05, which is a difference of $7.15.
We like to see positive, upward trending shares, preferably with momentum.
Market capitalization is $18.39 M and total net profit is $1537985 which means the company is trading at 11.96 times profit to market capitalization. Theoretically, if you were to buy Plant Advanced Technologies SA for $18.39 M, it would take 15 years to get your money back. Plant Advanced Technologies SA are in the Biotechnology space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
1 D | All
Financials
Plant Advanced Technologies SA Stock Forecast - Is Plant Advanced Technologies SA a Buy or Sell?
| DCF Score | | Strong Buy |
| ROE Score | | Neutral |
| ROA Score | | Neutral |
| DE Score | | Buy |
| PE Score | | Strong Sell |
| PB Score | | Strong Buy |
| Overall Recommendation | | Buy |
Growth and Value
| PE Ratio |
-87.734 |
| Dividend Yiel |
0.000 |
| Net Profit Margin |
-0.163 |
Valuing Plant Advanced Technologies SA
| Price Book Value Ratio |
1.967 |
Price To Book Ratio |
1.967 |
| Price To Sales Ratio |
14.292 |
Price Earnings Ratio |
-87.734 |
How liquid is Plant Advanced Technologies SA
| Current Ratio |
2.401 |
| Quick Ratio |
0.249 |
Debt
| Debt Ratio |
0.431 |
Debt Equity Ratio |
0.758 |
| Long Term Debt To Capitalization |
0.356 |
Total Debt To Capitalization |
0.000 |
Latest news about Plant Advanced Technologies SA
About Plant Advanced Technologies SA
CEO : Jean-Paul Fevre
Sector : Healthcare
Industry : Biotechnology
Website : https://www.plantadvanced.com
Description :
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include PAT Plant Milking that produces active extracts through plant stimulation and living-root exudation while preserving plants; PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes; and PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous plants to produce outside their leaf in a sterile closed pitcher. The company was founded in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.
